Morgan Stanley raised the firm’s price target on Tenet Healthcare (THC) to $260 from $247 and keeps an Overweight rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on THC:
- Tenet Healthcare price target raised to $277 from $253 at RBC Capital
- Tenet Healthcare price target raised to $250 from $225 at KeyBanc
- Tenet Healthcare Earnings Call Balances Growth and Risks
- Morning Movers: Unity plunges following fourth quarter report
- Tenet Healthcare reports Q4 adjusted EPS $4.70, consensus $4.05